| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |